MAM
PRP Group welcomes Shailja Patyal back as vice-president
Mumbai: PRP Group has appointed Shailja Patyal as vice president of PR Professionals, marking her return to the senior leadership team. With over 16 years of experience in communications and marketing strategy, Shailja’s comeback promises to drive the group forward, focusing on enhancing client management, stakeholder engagement, and team collaboration.
Patyal’s strategic vision at PR Professionals will align teams to foster better communication with clients and ensure seamless service delivery. Known for her collaborative leadership style, she excels at bringing together diverse teams to leverage their strengths and achieve common goals.
Prior to rejoining PRP, Patyal held key positions at multinational companies such as SMEC – A Surbana Jurong Group, Systra India, and IL&FS, where she showcased her leadership abilities and strategic acumen. Her expertise spans marketing strategies, organisational development, people communications, client relationships, and conflict management.
PR Professionals, founder & managing director, Sarvesh Tiwari expressed his excitement: “We are absolutely delighted to welcome Shailja back to the PRP Group. She was instrumental in our early days, playing a pivotal role in shaping the company’s foundation and her return brings valuable experience and strategic insight that will propel PRP forward.”
Patyal, equally thrilled, shared: “Coming back to PR Professionals feels like a homecoming. The warm reception from the team and management has been incredible, and it feels as though I’ve never been away. I am excited to collaborate with this talented team and contribute to the company’s ongoing success in my second innings with PRP.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
